MAY 13, 2015 1:30 PM PDT

More from Less- High Quality Data from Low Quality Samples

Speakers
  • Product Marketing Manager, Target Enrichment, New England Biolabs
    Biography
      Andrew Barry is the Product Marketing Manager for Target Enrichment at New England Biolabs. He has a B.S. in Biology from Stonehill College, and Master of Science in Biomedical Engineering from Tufts University. Prior to joining NEB Andrew spent the first 10 years of his career at the Broad Institute of MIT and Harvard where he developed high-throughput processes for genomic applications. Following his time at the Broad, he joined Caliper Life Sciences (later acquired by PerkinElmer) where he held various positions in product management, strategic marketing, and R&D. Andrew joined New England Biolabs in 2016.

    Abstract:

    The continued growth of DNA sequencing as a fundamental data output has driven the need for the ability to generate high quality data from an increasing breadth of diminishing primary sample inputs. As researchers and clinicians continue to develop associations between nucleic acid variants and disease and treatment response mechanisms, it has become increasingly important to maximize the data yield from available sample materials. The Broad Institute Genomics Platform has developed several strategies to mitigate the impact of low quality or low input sample materials on the data integrity for sample and cohort studies. These include improved protocols for nucleic acid extraction and sample preparation, implementation of quality control assays, and improved analytical tools for the identification and filtering of data artifacts. Here, we will discuss the types of quality issues that we observe, and the corresponding strategies that have been developed to overcome these.


    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources